Choice of Antiretroviral Drugs for Postexposure Prophylaxis for Children: A Systematic Review | Zendy

Martina Penazzato | Zendy; Karen Dominguez | Zendy; Mark F. Cotton | Zendy; Linda BarlowMosha | Zendy; Nathan Ford | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Choice of Antiretroviral Drugs for Postexposure Prophylaxis for Children: A Systematic Review

Author(s) -

Martina Penazzato,

Karen Dominguez,

Mark F. Cotton,

Linda BarlowMosha,

Nathan Ford

Publication year - 2015

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/civ110

Subject(s) - medicine , nevirapine , zidovudine , lamivudine , abacavir , regimen , ritonavir , adverse effect , lopinavir , hazard ratio , atazanavir , randomized controlled trial , confidence interval , viral load , human immunodeficiency virus (hiv) , antiretroviral therapy , immunology , viral disease , virus , hepatitis b virus

This systematic review aimed to assess the safety and efficacy of antiretroviral options for postexposure prophylaxis (PEP). Recognizing the limited data on the safety and efficacy of antiretroviral drugs for PEP in children, this review was extended to include consideration of data on the use of antiretroviral drugs for treatment of infants and children living with human immunodeficiency virus.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research